Societal CDMO, Inc. Logo

Societal CDMO, Inc.

SCTL

(1.5)
Stock Price

1,10 USD

-12.05% ROA

-15.05% ROE

-8.69x PER

Market Cap.

116.130.300,00 USD

65.12% DER

0% Yield

-11.75% NPM

Societal CDMO, Inc. Stock Analysis

Societal CDMO, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Societal CDMO, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.55x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a reasonable amount of debt compared to its ownership (80%), suggesting a balanced financial position and a moderate level of risk.

3 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

4 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 ROE

The stock's ROE indicates a negative return (-63.52%) on shareholders' equity, suggesting poor financial performance.

7 ROA

The stock's ROA (-31.04%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-1), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Societal CDMO, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Societal CDMO, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Societal CDMO, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Societal CDMO, Inc. Revenue
Year Revenue Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 51.952.000 100%
2016 69.337.000 25.07%
2017 71.834.000 3.48%
2018 77.347.000 7.13%
2019 99.219.000 22.04%
2020 66.499.000 -49.2%
2021 75.360.000 11.76%
2022 90.214.000 16.47%
2023 110.876.000 18.64%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Societal CDMO, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2011 1.828.301
2012 541.951 -237.36%
2013 543.632 0.31%
2014 7.874.187 93.1%
2015 12.281.000 35.88%
2016 33.278.000 63.1%
2017 33.095.000 -0.55%
2018 39.985.000 17.23%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Societal CDMO, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 485.257
2012 339.255 -43.04%
2013 546.119 37.88%
2014 3.997.596 86.34%
2015 13.017.000 69.29%
2016 12.742.000 -2.16%
2017 25.426.000 49.89%
2018 36.879.000 31.06%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Societal CDMO, Inc. EBITDA
Year EBITDA Growth
2011 -2.311.318
2012 -794.233 -191.01%
2013 -1.088.262 27.02%
2014 -11.861.239 90.83%
2015 2.732.000 534.16%
2016 -8.793.000 131.07%
2017 -24.495.000 64.1%
2018 -42.165.000 41.91%
2019 34.947.000 220.65%
2020 -5.759.000 706.82%
2021 1.449.000 497.45%
2022 8.597.000 83.15%
2023 23.636.000 63.63%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Societal CDMO, Inc. Gross Profit
Year Gross Profit Growth
2011 0
2012 0 0%
2013 0 0%
2014 -7.874.000 100%
2015 23.898.000 132.95%
2016 32.185.000 25.75%
2017 33.641.000 4.33%
2018 34.187.000 1.6%
2019 48.238.000 29.13%
2020 12.365.000 -290.12%
2021 19.823.000 37.62%
2022 23.138.000 14.33%
2023 34.304.000 32.55%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Societal CDMO, Inc. Net Profit
Year Net Profit Growth
2011 -2.870.918
2012 -1.536.536 -86.84%
2013 -1.957.818 21.52%
2014 -16.134.158 87.87%
2015 3.033.000 631.95%
2016 -30.205.000 110.04%
2017 -50.080.000 39.69%
2018 -79.723.000 37.18%
2019 -38.436.000 -107.42%
2020 -46.660.000 17.63%
2021 -26.504.000 -76.05%
2022 -19.881.000 -33.31%
2023 -3.144.000 -532.35%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Societal CDMO, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 -1
2012 0 0%
2013 0 0%
2014 -3 100%
2015 0 0%
2016 -3 100%
2017 -3 0%
2018 -4 33.33%
2019 -2 -200%
2020 -2 0%
2021 -1 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Societal CDMO, Inc. Free Cashflow
Year Free Cashflow Growth
2011 -2.172.283
2012 -1.224.850 -77.35%
2013 -816.625 -49.99%
2014 -10.866.217 92.48%
2015 6.047.000 279.7%
2016 -6.972.000 186.73%
2017 -23.733.000 70.62%
2018 -53.723.000 55.82%
2019 -33.839.000 -58.76%
2020 464.000 7392.89%
2021 5.569.000 91.67%
2022 -11.995.000 146.43%
2023 637.000 1983.05%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Societal CDMO, Inc. Operating Cashflow
Year Operating Cashflow Growth
2011 -2.172.283
2012 -1.224.850 -77.35%
2013 -816.625 -49.99%
2014 -10.866.217 92.48%
2015 8.458.000 228.47%
2016 -3.202.000 364.15%
2017 -17.042.000 81.21%
2018 -43.115.000 60.47%
2019 -25.497.000 -69.1%
2020 8.067.000 416.07%
2021 10.858.000 25.7%
2022 -3.644.000 397.97%
2023 1.371.000 365.79%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Societal CDMO, Inc. Capital Expenditure
Year Capital Expenditure Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 2.411.000 100%
2016 3.770.000 36.05%
2017 6.691.000 43.66%
2018 10.608.000 36.92%
2019 8.342.000 -27.16%
2020 7.603.000 -9.72%
2021 5.289.000 -43.75%
2022 8.351.000 36.67%
2023 734.000 -1037.74%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Societal CDMO, Inc. Equity
Year Equity Growth
2011 -13.611.633
2012 -15.561.877 12.53%
2013 2.336 666276.24%
2014 18.928.589 99.99%
2015 40.350.000 53.09%
2016 71.613.000 43.66%
2017 28.848.000 -148.24%
2018 -19.500.000 247.94%
2019 -6.712.000 -190.52%
2020 -14.100.000 52.4%
2021 42.064.000 133.52%
2022 59.859.000 29.73%
2023 58.663.000 -2.04%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Societal CDMO, Inc. Assets
Year Assets Growth
2011 25.698
2012 154.072 83.32%
2013 1.026.112 84.98%
2014 20.373.620 94.96%
2015 138.697.000 85.31%
2016 182.997.000 24.21%
2017 186.226.000 1.73%
2018 155.493.000 -19.76%
2019 110.459.000 -40.77%
2020 103.415.000 -6.81%
2021 160.317.000 35.49%
2022 157.443.000 -1.83%
2023 153.474.000 -2.59%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Societal CDMO, Inc. Liabilities
Year Liabilities Growth
2011 13.637.331
2012 15.715.949 13.23%
2013 1.023.776 -1435.1%
2014 1.445.031 29.15%
2015 98.347.000 98.53%
2016 111.384.000 11.7%
2017 157.378.000 29.23%
2018 174.993.000 10.07%
2019 117.171.000 -49.35%
2020 117.515.000 0.29%
2021 118.253.000 0.62%
2022 97.584.000 -21.18%
2023 94.811.000 -2.92%

Societal CDMO, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.9
Net Income per Share
-0.13
Price to Earning Ratio
-8.69x
Price To Sales Ratio
1.23x
POCF Ratio
-99.35
PFCF Ratio
-12.36
Price to Book Ratio
1.97
EV to Sales
2
EV Over EBITDA
37.02
EV to Operating CashFlow
-163.13
EV to FreeCashFlow
-20.15
Earnings Yield
-0.12
FreeCashFlow Yield
-0.08
Market Cap
0,12 Bil.
Enterprise Value
0,19 Bil.
Graham Number
1.26
Graham NetNet
-0.57

Income Statement Metrics

Net Income per Share
-0.13
Income Quality
0.09
ROE
-0.23
Return On Assets
-0.06
Return On Capital Employed
0.01
Net Income per EBT
1.01
EBT Per Ebit
-10.17
Ebit per Revenue
0.01
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
0.23
Operating Profit Margin
0.01
Pretax Profit Margin
-0.12
Net Profit Margin
-0.12

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.09
Capex to Operating CashFlow
7.09
Capex to Revenue
-0.09
Capex to Depreciation
-0.92
Return on Invested Capital
-0.02
Return on Tangible Assets
-0.12
Days Sales Outstanding
113.44
Days Payables Outstanding
6.33
Days of Inventory on Hand
49.53
Receivables Turnover
3.22
Payables Turnover
57.64
Inventory Turnover
7.37
Capex per Share
-0.08

Balance Sheet

Cash per Share
0,08
Book Value per Share
0,56
Tangible Book Value per Share
0.15
Shareholders Equity per Share
0.56
Interest Debt per Share
0.4
Debt to Equity
0.65
Debt to Assets
0.25
Net Debt to EBITDA
14.32
Current Ratio
1.07
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
-0,04 Bil.
Invested Capital
0.65
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.28
Average Receivables
0,03 Bil.
Average Payables
0,00 Bil.
Average Inventory
11270500
Debt to Market Cap
0.33

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Societal CDMO, Inc. Dividends
Year Dividends Growth

Societal CDMO, Inc. Profile

About Societal CDMO, Inc.

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

CEO
Mr. J. David Enloe Jr.
Employee
258
Address
1 E. Uwchlan Ave
Exton, 19341

Societal CDMO, Inc. Executives & BODs

Societal CDMO, Inc. Executives & BODs
# Name Age
1 Ms. Erica Raether M.A.
Senior Vice President & Chief People Officer
70
2 Mr. Marshall Rizzo M.B.A.
Senior Vice President & Chief Operating Officer
70
3 Mr. Wayne B. Weisman J.D.
Executive Chairman of the Board
70
4 Mr. J. David Enloe Jr.
President, Chief Executive Officer & Director
70
5 Mr. Ryan D. Lake CPA
Senior Vice President & Chief Financial Officer
70
6 Ms. Cristin Grove
Vice President of Sales
70
7 Mr. Richard Sidwell Ph.D.
Senior Vice President & Chief Scientific Officer
70

Societal CDMO, Inc. Competitors